Class ITerminated in FDA datasetRecall initiated Dec 17, 2015

Zatarain's New Orleans Style RED BEANS AND RICE, ORIGINAL, NET WT 8 OZ

Recalling firm: Zatarain's Partnership, L.P.

Why it was recalled

Zatarain's is initiating a voluntary recall of Zatarain's Red Beans And Rice Original 8 oz. package, USPC 7142909849 with date code of BEST BY JUL 31 16Z as it may contain…

Historical recall record. This is not a new recall announcement. “Terminated” describes the FDA recall process; it does not certify that an individual package is safe. FDA termination date: Oct 31, 2016.

Check your package

Compare the exact product and package details with the label you have.

ProductZatarain's New Orleans Style RED BEANS AND RICE, ORIGINAL, NET WT 8 OZ, UPC 7142909849
Package size8 OZ

FDA code information

BEST BY JUL 31 16Z

Match the product, package size, and code together. A missing match does not guarantee safety.

Full FDA record and distribution details

Original product description

Zatarain's New Orleans Style RED BEANS AND RICE, ORIGINAL, NET WT 8 OZ, UPC 7142909849

Original FDA recall reason

Zatarain's is initiating a voluntary recall of Zatarain's Red Beans And Rice Original 8 oz. package, USPC 7142909849 with date code of BEST BY JUL 31 16Z as it may contain Creamy Parmesan Rice Mix which has a dairy allergen (milk).

Recall details

Recall number
F-0462-2016
Event ID
72883
FDA status
Terminated
Initiated
Dec 17, 2015
Reported
Feb 10, 2016
Classified
Feb 1, 2016
Terminated
Oct 31, 2016
Quantity
1656 units
Location
Gretna, LA, United States
Initiation type
Voluntary: Firm initiated
Notification
Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit

Where it was distributed

Florida, Georgia, Illinois, Indiana, Kentucky, Louisiana, Massachusetts, Maine, Michigan, Minnesota, Mississippi, North Carolina, New York, Ohio, Pennsylvania, South Carolina, Tennessee, Virginia and Wisconsin

FDA source record · F-0462-2016

Data updated September 16, 2026. View official FDA data ↗

Follow official FDA and manufacturer guidance.